Summary of baseline characteristics
Parameter . | Adults (n = 9) . | Children (n = 5) . | Combined (N = 14) . |
---|---|---|---|
Age, y | |||
Mean (SD) | 31.9 (7.56) | 10.8 (5.26) | 24.4 (12.39) |
Median | 33.0 | 11.0 | 24.0 |
Min, max | 20, 42 | 5, 16 | 5, 42 |
Sex, n (%) | |||
Male | 3 (33) | 1 (20) | 4 (29) |
Female | 6 (67) | 4 (80) | 10 (71) |
Baseline plasminogen activity, n (%) | |||
0% to 10% | 3 (33) | 0 | 3 (21) |
11% to 20% | 1 (11) | 2 (40) | 3 (21) |
21% to 30% | 3 (33) | 3 (60) | 6 (43) |
31% to 40% | 1 (11) | 0 | 1 (7) |
41% to 45% | 1 (11) | 0 | 1 (7) |
>45% | 0 | 0 | 0 |
Site of clinical manifestations, n (%) | |||
Any* | 8 (89) | 3 (60) | 11 (79) |
Conjunctiva | 6 (67) | 2 (40) | 8 (57) |
Gingiva | 3 (33) | 0 | 3 (21) |
Abnormal wound healing | 3 (33) | 0 | 3 (21) |
Bronchus | 2 (22) | 0 | 2 (14) |
Colon | 0 | 2 (40) | 2 (14) |
Cervix | 2 (22) | 0 | 2 (14) |
Vagina | 0 | 2 (40) | 2 (14) |
Nasopharynx | 1 (11) | 0 | 1 (7) |
Kidney | 1 (11) | 0 | 1 (7) |
Multisystem | 6 (67) | 3 (60) | 9 (64) |
Parameter . | Adults (n = 9) . | Children (n = 5) . | Combined (N = 14) . |
---|---|---|---|
Age, y | |||
Mean (SD) | 31.9 (7.56) | 10.8 (5.26) | 24.4 (12.39) |
Median | 33.0 | 11.0 | 24.0 |
Min, max | 20, 42 | 5, 16 | 5, 42 |
Sex, n (%) | |||
Male | 3 (33) | 1 (20) | 4 (29) |
Female | 6 (67) | 4 (80) | 10 (71) |
Baseline plasminogen activity, n (%) | |||
0% to 10% | 3 (33) | 0 | 3 (21) |
11% to 20% | 1 (11) | 2 (40) | 3 (21) |
21% to 30% | 3 (33) | 3 (60) | 6 (43) |
31% to 40% | 1 (11) | 0 | 1 (7) |
41% to 45% | 1 (11) | 0 | 1 (7) |
>45% | 0 | 0 | 0 |
Site of clinical manifestations, n (%) | |||
Any* | 8 (89) | 3 (60) | 11 (79) |
Conjunctiva | 6 (67) | 2 (40) | 8 (57) |
Gingiva | 3 (33) | 0 | 3 (21) |
Abnormal wound healing | 3 (33) | 0 | 3 (21) |
Bronchus | 2 (22) | 0 | 2 (14) |
Colon | 0 | 2 (40) | 2 (14) |
Cervix | 2 (22) | 0 | 2 (14) |
Vagina | 0 | 2 (40) | 2 (14) |
Nasopharynx | 1 (11) | 0 | 1 (7) |
Kidney | 1 (11) | 0 | 1 (7) |
Multisystem | 6 (67) | 3 (60) | 9 (64) |
Max, maximum; min, minimum.
Three patients (2 children and 1 adult) had no clinical manifestations at baseline.